Börse:
Echtzeit-Aktienkurs ONCOLYTICS BIOTECH
Bid:
Ask:
| Allgemeine Informationen | ||
|---|---|---|
| Börsenwert: | - | |
| Website: | - | |
| Sektor: | Medizin / Biotechnologie | |
| News-Radar | |
|---|---|
| dpa-AFX Pro - | Newsbot - |
| dpa-AFX - | Reuters - |
| 2014 | 2015 | 2016 | 2017 | |
|---|---|---|---|---|
| KUV | - | - | - | - |
| KGV | - | - | - | - |
| Div. Rend. | - | - | - | - |
Echtzeit-Chart der ONCOLYTICS BIOTECH Aktie
Börsenkurse ONCOLYTICS BIOTECH
| Lang & Schwarz | 0,600€ | 4615 | 0,700€ | 4615 | 0,650€ | 0,00% |
| Tradegate | - | - | - | - | - | - |
Fundamentaldaten der ONCOLYTICS BIOTECH Aktie
Aktuelle Geschäftsentwicklung
Sie benötigen die TraderFox Börsensoftware, um die aktuelle Geschäftsentwicklung einsehen zu können.
Income Statement: 10-Year-Summary
| Datum | Umsatz | EBIT | Gewinn | EPS | Dividende | KGV | KUV |
|---|---|---|---|---|---|---|---|
| 2017 | - | -15,48 Mio. | -15,62 Mio. | -1,14 | - | - | - |
| 2016 | - | -15,13 Mio. | -15,14 Mio. | -1,24 | - | - | - |
| 2015 | - | -13,72 Mio. | -13,72 Mio. | -1,14 | - | - | - |
| 2014 | - | -18,61 Mio. | -18,62 Mio. | -2,00 | - | - | - |
| 2013 | - | -23,53 Mio. | -23,53 Mio. | -2,66 | - | - | - |
| 2012 | - | -36,34 Mio. | -36,37 Mio. | -4,56 | - | - | - |
| 2011 | - | -29,00 Mio. | -29,05 Mio. | -3,90 | - | - | - |
| 2010 | - | -19,97 Mio. | -19,97 Mio. | -3,04 | - | - | - |
| 2009 | - | -16,21 Mio. | -16,23 Mio. | -3,14 | - | - | - |
Profil der ONCOLYTICS BIOTECH Aktie
Oncolytics Biotech, Inc. is a biotechnology company, which engages in the research and development of oncolytic viruses for use as cancer therapeutics. It develops a proprietary formulation of the human reovirus under the REOLYSIN product name. The company was founded by Matthew C. Coffey and Bradley George Thompson on April 2, 1998 and is headquartered in Calgary, Canada.
TraderFox GmbH:
Impressum & Datenschutz -
Allgemeine Geschäftsbedingungen